Decision-Making Process of Women Carrying a BRCA1 or BRCA2 Mutation Who Have Chosen Prophylactic Mastectomy

Megan McQuirter

Luisa Luciani Castiglia

Carmen Loiselle

Nora Wong

BRCA1, Brca 1 gene, Brca2 gene, breast neoplasms
ONF 2010, 37(3), 313-320. DOI: 10.1188/10.ONF.313-320

Purpose/Objectives: To explore the decision-making process of women with a BRCA1 or BRCA2 gene mutation who have chosen to undergo prophylactic mastectomy.

Design: Cross-sectional, qualitative, descriptive design.

Setting: Participants were recruited from an outpatient cancer prevention center in the oncology and medical genetics departments of a large university-affiliated hospital in Montreal, Quebec, Canada.

Sample: 10 women carrying a BRCA1 or BRCA2 mutation; 8 previously had had a prophylactic mastectomy and 2 were scheduled for surgery at the time of study.

Methods: Semistructured, in-depth interviews were conducted. Field notes were written and audiotapes were transcribed verbatim. The textual data were coded and analyzed.

Main Research Variables: Decision-making process for prophylactic mastectomy.

Findings: Two broad findings emerged. First, several intrapersonal and contextual factors interacted throughout the process to move women either closer to choosing a prophylactic mastectomy or further from the decision. Second, all women reported experiencing a "pivotal point," an emotionally charged event when the decision to have a prophylactic mastectomy became definitive. Pivotal points for patients included either receiving a positive result for a genetic mutation or a breast cancer diagnosis for herself or a family member in the context of positive mutation status.

Conclusions: Decision making about prophylactic mastectomy was an affective and intuitive process incorporating contexts and their relations rather than a rational, straight-forward process of weighing pros and cons.

Implications for Nursing: Supportive interventions for women in this population should explicitly address the individual and the inter-relationships of contextual factors that shape decision making about prophylactic mastectomy while recognizing important affective components involved.

Jump to a section


    Bebbington Hatcher, M., & Fallowfield, L. J. (2003). A qualitative study looking at the psychosocial implications of bilateral prophylactic mastectomy. Breast, 12, 1-9. doi: 10.1016/S0960-9776(02)00135-2
    Bleiker, E. M., Hahn, D. E., & Aaronson, N. K. (2003). Psychosocial issues in cancer genetics: Current status and future directions. Acta Oncologica, 42, 276-286. doi: 10.1080/02841860310004391
    Broadstock, M., & Michie, S. (2000). Processes of patient decision making: Theoretical and methodological issues. Psychology and Health, 15, 191-204. doi: 10.1080/08870440008400300
    Burnard, P. (1991). A method of analysing interview transcripts in qualitative research. Nurse Education Today, 11, 461-466.
    Carlick, A., & Biley, F. C. (2004). Thoughts on the therapeutic use of narrative in the promotion of coping in cancer care. European Journal of Cancer Care, 13, 308-317. doi: 10.1111/j.1365-2354.2004.00466.x
    Carnevale, F. A. (2002). Authentic qualitative research and the quest for methodological rigour. Canadian Journal of Nursing Research, 34, 121-128.
    Chen, S., & Parmigiani, G. (2007). Meta-analysis of BRCA1 and BRCA2 penetrance. Journal of Clinical Oncology, 25, 1329-1333. doi: 10.1200/JCO.2006.09.1066
    De Leeuw, J. R., van Vliet, M. J., & Auseums, M. G. (2008). Predictors of choosing life-long screening or prophylactic surgery in women at high risk and moderate risk for breast and ovarian cancer. Familial Cancer, 7, 347-359. doi: 10.1007/s10689-008-9189-5
    Egan, G. (2007). The skilled helper: A problem-management and opportunity- development approach to helping (8th ed.). Pacific Grove, CA: Brooks/Cole.
    Eisinger, F., Julian-Reynier, C., Stoppa-Lyonnet, D., Lasset, C., & Nogues, C. (2000). Acceptability of prophylactic mastectomy in cancer-prone women. JAMA, 283, 197-203. doi: 10.1001/jama.283.2.202
    Frost, M. H., Slezak, J. M., Tran, N. V., Williams, C. I., Johnson, J. L., Woods, J. E., … Hartmann, L. C. (2005). Satisfaction after contralateral prophylactic mastectomy: The significance of mastectomy type, reconstructive complications, and body appearance. Journal of Clinical Oncology, 23, 7849-7856. doi: 10.1200/JCO.2005.09.233
    Gottlieb, L. N., & Gottlieb, B. (2007). The developmental/health framework within the McGill Model of Nursing: "Laws of nature" guiding whole person care. Advances in Nursing Science, 30, E43-E57.
    Hack, T. F., Degner, L. F., Watson, P., & Sinha, L. (2006). Do patients benefit from participating in medical decision-making? Longitudinal follow-up of women with breast cancer. Psycho-Oncology, 15, 9-19. doi: 10.1002/pon.907
    Hallowell, N. (1998). "You don't want to lose your ovaries because you think ‘I might become a man’": Women's perceptions of prophylactic surgery as a cancer risk management option. Psycho-Oncology, 7, 263-275.
    Janz, N. K., Wren, P. A., Copeland, L. A., Lowery, J. C., Goldfarb, S. L., & Wilkins, E. G. (2004). Patient-physician concordance: Preferences, perceptions, and factors influencing the breast cancer surgical decision. Journal of Clinical Oncology, 22, 3091-3098. doi: 10.1200/JCO.2004.09.069
    Kenny, P., Quine, S., Shiell, A., & Cameron, S. (1999). Participation in treatment decision-making by women with early stage breast cancer. Health Expectations, 2, 159-168. doi: 10.1046/j.1369-6513.1999.00050.x
    Kurian, A. W., Hartman, A. R., Mills, M. A., Ford, J. M., Daniel, B. L., & Plevritis, S. K. (2005). Opinions of women with high inherited breast cancer risk about prophylactic mastectomy: An initial evaluation from a screening trial including magnetic resonance imaging and ductal lavage. Health Expectations, 8, 221-233. doi: 10.1111/j.1369-7625.2005.00333.x
    Lacey, M. D. (2002). The experience of using decisional support aids by patients with breast cancer. Oncology Nursing Forum, 29, 1491-1497. doi: 10.1188/02.ONF.1491-1497
    Lloyd, S. M., Watson, M., Oaker, G., Sacks, N., Rovere, U. Q., & Gui, G. (2000). Understanding the experience of prophylactic bilateral mastectomy: A qualitative study of ten women. Psycho-Oncology, 9, 473-485.
    Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Seynaeve, C., … Niermeijer, M. F. (2002). One year followup of women opting for presymptomatic testing for BRCA1 and BRCA2: Emotional impact of the test outcome and decisions on risk management (surveillance or prophylactic surgery). Breast Cancer Research and Treatment, 73, 97-112. doi: 10.1023/A:1015269620265
    Loiselle, C. G., Profetto-McGrath, J., Polit, D. F., & Beck, C. T. (2007). Canadian essentials of nursing research (2nd ed.). Philadelphia, PA: Lippincott Williams and Wilkins.
    McCaul, K. D., Peters, E., Nelson, W., & Stefanek, M. (2005). Linking decision-making research and cancer prevention and control: Important themes. Health Psychology, 24(4, Suppl.), S106-S110. doi: 10.1037/0278-6133.24.4.S106
    McCullum, M., Bottorff, J. L., Kelly, M., Kieffer, S. A., & Balneaves, L. G. (2007). Time to decide about risk-reducing mastectomy: A case series of BRCA1/2 gene mutation carriers. BioMed Central Women's Health, 7(3), 1-9.
    McGaughey, A. (2006). Body image after bilateral prophylactic mastectomy: An integrative literature review. Journal of Midwifery and Women's Health, 51, E45-E49. doi: 10.1016/j.jmwh.2006.07.002
    Meiser, B., Butow, P., Friedlander, M., Schnieden, V., Gattas, M., Kirk, J., … Tucker, K. (2000). Intention to undergo prophylactic bilateral mastectomy in women at increased risk of developing hereditary breast cancer. Journal of Clinical Oncology, 18, 2250-2257.
    Meiser, B., Butow, P., Price, M., Bennet, B., Berry, G., & Tucker, K. (2003). Attitudes to prophylactic surgery and chemoprevention in Australian women at increased risk for breast cancer. Journal of Women's Health, 12, 769-778. doi: 10.1089/154099903322447738
    Metcalfe, K. A., Esplen, M. J., Goel, V., & Narod, S. A. (2004). Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy. Psycho-Oncology, 13, 14-25. doi: 10.1002/pon.726
    Metcalfe, K. A., Foulkes, W. D., Kim-Sing, C., Ainsworth, P., Rosen, B., Armel, S., … Narod, S. A. (2008). Family history as a predictor of uptake of cancer preventive procedures by women with BRCA1 or BRCA2 mutation. Clinical Genetics, 73, 474-479. doi: 10.1111/j.1399 0004.2008.00988.x
    Metcalfe, K. A., Lubinski, J., Ghadirian, P., Lynch, H., Kim-Sing, C., Friedman, E., … Narod, S. A. (2008). Predictors of contralateral prophylactic mastectomy in women with a BRCA1 or BRCA2 mutation: The heredity breast cancer clinical study group. Journal of Clinical Oncology, 26, 1093-1097. doi:10.1200/JCO.2007.12.6078
    Metcalfe, K. A., Poll, A., O'Connor, A., Gershman, S., Armel, S., Finch, A., … Narod, S. A. (2007). Development and testing of a decision aid for breast cancer prevention for women with a BRCA1 or BRCA2 mutation. Clinical Genetics, 72, 208-217. doi: 10.1111/j.1399-0004.2007.00859.x
    Morse, J. M., & Field, P. A. (1995). Principles of data collection. In Qualitative research methods for health professionals (2nd ed., pp. 89-124). Thousand Oaks, CA: Sage.
    National Cancer Institute. (2008). Genetics of breast and ovarian cancer. Retrieved from
    Patenaude, A. F., Orozco, S., Li, X., Kaelin, C. M., Gadd, M., Matory, Y., … Garber, J. E. (2008). Support needs and acceptability of psychological and peer consultation: Attitudes of 108 women who had undergone or were considering prophylactic mastectomy. Psycho-Oncology, 17, 831-843. doi: 10.1002/pon.1279
    Press, N., Reynolds, S., Pinsky, L., Murthy, V., Leo, M., & Burke, W. (2005). "That's like chopping off a finger because you're afraid it might get broken": Disease and illness in women's views of prophylactic mastectomy. Social Science and Medicine, 61, 1106-1117.
    Ray, J. A., Loescher, L. J., & Brewer, M. (2005). Risk-reduction surgery decisions in high-risk women seen for genetic counseling. Journal of Genetic Counseling, 14, 473-484. doi: 10.1007/s10897-005-5833-5
    Rebbeck, T. R., Friebel, T., Lynch, H. T., Neuhausen, S. L., van 't Veer, L., Garber, J. E., … Weber, B. L. (2004). Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers: The PROSE study group. Journal of Clinical Oncology, 22, 1055-1062. doi: 10.1200/JCO.2004.04.188
    Rogozinska-Szczepka, J., Utracka-Hutka, B., Grzybowska, E. Maka, B., Nowicka, E., Smok-Ragankiewicz, A., … Wojciechowska-Lacka, A. (2004). BRCA1 and BRCA2 mutations as prognostic factors in bilateral breast cancer patients. Annals of Oncology, 15, 1373-1376. doi: 10.1093/annonc/mdh352
    Rolnick, S. J., Altschuler, A., Nekhlyudov, L., Elmore, J. G., Greene, S. M., Harris, E. L., … Fletcher, S. W. (2007). What women wish they knew before prophylactic mastectomy. Cancer Nursing, 30, 285-291. doi: 10.1097/01.NCC.0000281733.40856.c4
    Sandelowski, M. (2000). Whatever happened to qualitative description? Research in Nursing and Health, 23, 334-340.
    Schwartz, M. D., Lerman, C., Brogan, B., Peshkin, B. N., Halbert, C. H., DeMarco, T., … Isaacs, C. (2004). Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients. Journal of Clinical Oncology, 22, 1823-1829. doi: 10.1200/JCO.2004.04.086
    Schwartz, M. D., Peshkin, B. N., Tercyak, K. P., Taylor, K. L., & Valdimarsdottir, H. (2005). Decision making and decision support for hereditary breast-ovarian cancer susceptibility. Health Psychology, 24(4, Suppl.), S78-S84. doi: 10.1037/0278-6133.24.4.S78
    Schwartz, M. D., Valdimarsdottir, H. B., DeMarco, T. A., Peshkin, B. N., Lawrence, W., Rispoli, J., … Komaridis, K. (2009). Randomized trial of a decision aid for BRCA1/BRCA2 mutation carriers: Impact on measures of decision making and satisfaction. Health Psychology, 28, 11-19. doi: 10.1037/a0013147
    Slovic, P., Peters, E., Finucane, M. L., & MacGregor, D. G. (2005). Affect, risk, and decision making. Health Psychology, 24(4, Suppl.), S35-S40. doi: 10.1037/0278-6133.24.4.S35
    Stefanek, M., Enger, C., Benkendorf, J., Honig, S. F., & Lerman, C. (1999). Bilateral prophylactic mastectomy decision making: A vignette study. Preventive Medicine, 29, 216-221. doi: 10.1006/pmed.1999.0524
    Stefanek, M. E., Helzlsouer, K. J., Wilcox, P. M., & Houn, F. (1995). Predictors of and satisfaction with bilateral prophylactic mastectomy. Preventative Medicine, 24, 412-419. doi:10.1006/pmed.1995.1066
    Ubel, P. A., & Lowenstein, G. (1997). The role of decision analysis in informed consent: Choosing between intuition and systematicity. Social Science and Medicine, 44, 647-656. doi: 10.1006/pmed.1995.1066
    Unic, I., Verhoef, L. C., Stalmeier, P. F., & van Daal, W. A. (2000). Prophylactic mastectomy or screening in women suspected to have the BRCA1/2 mutation: A prospective pilot study of women's treatment choices and medical decision-analytic recommendations. Medical Decision Making, 20, 251-262. doi: 10.1177/0272989X0002000301
    Vadaparampil, S. T., Wey, J. P., & Kinney, A. Y. (2004). Psychosocial aspects of genetic counseling and testing. Seminars in Oncology Nursing, 20, 186-195. doi: 10.1177/0272989X0002000301
    van Dijk, S., Otten, W., Zoeteweij, M. W., Timmermans, D. R., van Asperen, C. J., Breuning, M. H., … Kievit, J. (2003). Genetic counselling and the intention to undergo prophylactic mastectomy: Effects of a breast cancer risk assessment. British Journal of Cancer, 88, 1675-1168. doi: 10.1038/sj.bjc.6600988
    van Dijk, S., van Roosmalen, M., Otten, W., & Stalmeier, P. F. (2008). Decision making regarding prophylactic mastectomy: Stability of preferences and the impact of anticipated feelings of regret. Journal of Clinical Oncology, 26, 2358-2363. doi: 10.1200/JCO.2006.10.5494
    van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., Oosterwijk, J. C., Hoogerbrugge, N., … van Daal, W. A. (2004a). Impact of BRCA1/2 testing and disclosure of a positive test result on women affected and unaffected with breast or ovarian cancer. American Journal of Medical Genetics. Part A, 124A, 346-355.
    van Roosmalen, M. S., Stalmeier, P. F., Verhoef, L. C., Hoekstra-Weebers, J. E., Oosterwijk, J. C., Hoogerbrugge, N., … van Daal, W. A. (2004b). Randomized trial of a shared decision-making intervention consisting of trade-offs and individualized treatment information for BRCA1/2 mutation carriers. Journal of Clinical Oncology, 22, 3293-3301.
    van Sprundel, T. C., Schmidt, M., Rookus, M., Brohet, R., van Asperen, C. J., Rutgers, E., … Tollenaar, R. A. (2005). Risk reduction of contralateral breast cancer and survival after contralateral prophylactic mastectomy in BRCA1 or BRCA2 mutation carriers. British Journal of Cancer, 93, 287-292. doi:10.1038/sj.bjc.6602703
    Zakaria, S., & Degnim, A. C. (2007). Prophylactic mastectomy. Surgical Clinics of North America, 87, 317-331. doi: 10.1016/j.suc.2007.01.009